SCHEMBL6796941

SCHEMBL6796941

O=C(O)N1CCC(CS(=O)(=O)c2ccc(Oc3ccccc3)cc2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP3 P08254 4/20 0.56
MMP2 P08253 4/20 0.56
MMP1 P03956 4/20 0.56
MMP9 P14780 3/20 0.56
MMP8 P22894 3/20 0.56
MMP7 P09237 2/20 0.56
MMP14 P50281 2/20 0.56
ADAM17 P78536 1/20 0.56
SMN1; SMN2 Q16637 5/20 0.54
LMNA P02545 4/20 0.54
ALDH1A1 P00352 2/20 0.54
MMP13 P45452 4/20 0.51
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
AOC2 O75106 4/20 0.47
KMT2A Q03164 2/20 0.46
HTT P42858 3/20 0.46
MEN1 O00255 1/20 0.46
MAPT P10636 1/20 0.46
NPY2R P49146 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6789829 0.87 MMP2 (0.54) MMP3MMP2MMP1MMP9MMP8
SCHEMBL12020262 0.84 MMP2 (0.69) MMP3MMP2MMP1MMP9MMP8
SCHEMBL3040016 0.81 L3MBTL1 (0.46) NPC1RAB9AAOC2MAPT
SCHEMBL22557150 0.81 POLB (0.48) SMN1; SMN2ALDH1A1AOC2KMT2AHTT
SCHEMBL7749095 0.81 MMP2 (0.54) MMP3MMP2MMP1MMP9MMP8
Hydrochloric Acid SCHEMBL3043138 0.80 L3MBTL1 (0.45) NPC1RAB9AAOC2MAPT
SCHEMBL17942381 0.77 CACNA1B (0.48) MMP1AOC2KMT2AMEN1
SCHEMBL5743183 0.77 CTSK (0.46) MMP3MMP2MMP1MMP9MMP8
SCHEMBL12717527 0.76 MMP2 (0.52) MMP3MMP2MMP1MMP9MMP8
SCHEMBL17942367 0.75 AOC2 (0.43) SMN1; SMN2LMNAALDH1A1AOC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040097487-A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds G.D. SEARLE & CO. 2004-05-20 US disclosed
US-6638952-B1 Matrix metalloprotease inhibitors PHARMACIA CORPORATION 2003-10-28 US disclosed
EP-0983257-A4 AROMATIC SULFONYL ALPHA-CYCLOAMINO HYDROXAMIC ACID COMPOUNDS MONSANTO CO (US) 2001-05-02 EP disclosed
EP-0983257-A1 AROMATIC SULFONYL ALPHA-CYCLOAMINO HYDROXAMIC ACID COMPOUNDS Monsanto Company (US) 2000-03-08 EP disclosed
WO-1998039315-A1 AROMATIC SULFONYL ALPHA-CYCLOAMINO HYDROXAMIC ACID COMPOUNDS MONSANTO COMPANY (US) 1998-09-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097487-A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds MMP1, MMP2, MMP10 MMP3 5/4885MMP2 2/4885MMP1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.